Crossmark

Cost Analysis of Biologic Drugs in Rheumatoid Arthritis First Line Treatment After Methotrexate Failure According to Patients’ Body Weight

Crossref DOI link: https://doi.org/10.1016/j.reumae.2015.07.006

Published Print: 2016-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Román Ivorra, José Andrés

Ivorra, José

Monte-Boquet, Emilio

Canal, Cristina

Oyagüez, Itziar

Gómez-Barrera, Manuel
License Information

Text and Data Mining valid from 2016-05-01
More Information

This article is maintained by: Elsevier

Article Title: Cost Analysis of Biologic Drugs in Rheumatoid Arthritis First Line Treatment After Methotrexate Failure According to Patients’ Body Weight

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2015.07.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2015.07.008

Content Type: article

Copyright: © 2015 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.